Browsing by Author "Quandt, Zoe"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes
    (Sage, 2025-05-30) Mader, Julia K.; Wong, Jenise C.; Freckmann, Guido; Garcia-Tirado, Jose; Hirsch, Irl B.; Johnson, Suzanne Bennett; Kerr, David; Kim, Sun H.; Lal, Rayhan; Montaser, Eslam; O'Donnell, Holly; Pleus, Stefan; Shah, Viral N.; Ayers, Alessandra T.; Ho, Cindy N.; Biester, Torben; Dovc, Klemen; Farrokhi, Farnoosh; Fleming, Alexander; Gillard, Pieter; Heinemann, Lutz; López-Díez, Raquel; Maahs, David M.; Mathieu, Chantal; Quandt, Zoe; Rami-Merhar, Birgit; Wolf, Wendy; Klonoff, David C.; Medicine, School of Medicine
    This consensus report evaluates the potential role of continuous glucose monitoring (CGM) in screening for stage 2 type 1 diabetes (T1D). CGM offers a minimally invasive alternative to venous blood testing for detecting dysglycemia, facilitating early identification of at-risk individuals for confirmatory blood testing. A panel of experts reviewed current evidence and addressed key questions regarding CGM's diagnostic accuracy and screening protocols. They concluded that while CGM cannot yet replace blood-based diagnostics, it holds promise as a screening tool that could lead to earlier, more effective intervention. Metrics such as time above range >140 mg/dL could indicate progression risk, and artificial intelligence (AI)-based modeling may enhance predictive capabilities. Further research is needed to establish CGM-based diagnostic criteria and refine screening strategies to improve T1D detection and intervention.